Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform

Recruiting now

Conditions studied: Renal Tumors

In brief

This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indicative of response to systemic agents or ablative therapy.

Key facts

Study ID

NCT06868927

Run by

IRCCS San Raffaele

People needed

50

Starts

2025-09-26

Expected to finish

2029-12-31

Last updated by the study team

2026-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presence of a renal mass up to 4 cm
• Adult > 18 years
• Candidate to renal surgery
• Informed consent signed

You may not qualify if…

• Contraindication for MRI

Where it is running

• IRCCS Ospedale San Raffaele — Milan, Italia, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.